Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells  by Kuwayama, Kenji et al.
Available online at www.sciencedirect.com
ta 1778 (2008) 42–50
www.elsevier.com/locate/bbamemBiochimica et Biophysica AcUptake of 3,4-methylenedioxymethamphetamine and its related compounds
by a proton-coupled transport system in Caco-2 cells
Kenji Kuwayama a,b,⁎, Hiroyuki Inoue a, Tatsuyuki Kanamori a, Kenji Tsujikawa a,
Hajime Miyaguchi a, Yuko Iwata a, Seiji Miyauchi b, Naoki Kamo b, Tohru Kishi a
a National Research Institute of Police Science, 6-3-1, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan
b Laboratory of Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan
Received 15 April 2007; received in revised form 24 August 2007; accepted 27 August 2007
Available online 8 September 2007Abstract
3,4-Methylenedioxymethamphetamine (MDMA) is an illegal amphetamine-type stimulant (ATS) that is abused orally in the form of tablets for
recreational purposes. The aim of this work is to investigate the absorption mechanism of MDMA and other related compounds that often occur
together in ATS tablets, and to determine whether such tablet components interact with each other in intestinal absorption. The characteristics of
MDMA uptake by the human intestinal epithelial Caco-2 cell line were investigated. The Michaelis constant and the maximal uptake velocity at
pH 6.0 were 1.11 mM and 13.79 nmol/min/mg protein, respectively, and the transport was electroneutral. The initial uptake rate was regulated by
both intra- and extracellular pH. MDMA permeation from the apical to the basolateral side was inferior to that in the reverse direction, and a
decrease in apical pH enhanced MDMA permeation from the basolateral to the apical side. These facts indicate that this transport system may be
an antiporter of H+. However, under physiological conditions, the proton gradient cannot drive the MDMA uptake because it is inwardly directed.
Large concentration differences of MDMA itself drive this antiporter. Various compounds with similar amine moieties inhibited the uptake, but
substrates of organic cation transporters (OCT1–3) and an H+-coupled efflux antiporter, MATE, were not recognized.
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There has been a considerable increase in the number of
seizures induced by amphetamine-type stimulant (ATS) tablets
in Japan [1]. The abuse of ATS tablets has become a serious
social problem not only in Japan but throughout the world. ATS
tablets contain one or more active ingredients such as 3,4-me-
thylenedioxymethamphetamine (MDMA), 3,4-methylenediox-
yamphetamine (MDA), 3,4-methylenedioxyethylamphetamine
(MDEA), methamphetamine (MA), etc. [2–8]. These compo-
nents are similar to each other in their pharmacological and
toxicological effects, and affect the central nervous system. In
addition, the tablets often contain other components having
a hallu1cinogenic and/or stimulant effect, such as ketamine and⁎ Corresponding author. Tel.: +81 4 7135 8001; fax: +81 4 7133 9173.
E-mail address: kuwayama@nrips.go.jp (K. Kuwayama).
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doi:10.1016/j.bbamem.2007.08.023caffeine. Various components in such tablets might interact with
each other in the body, leading to serious toxic symptoms.
Because MDMA is the major component in such tablets and
can easily be taken orally, it is a matter of urgency for public
health and forensic toxicology to elucidate the intestinal absorp-
tion mechanism of MDMA and the interactions among com-
ponents in ATS tablets. To the best of our knowledge, there is
little information regarding the intestinal absorption of MDMA
[9], although the pharmacological effects of MDMA and the
transporters of neurotransmitters such as dopamine and seroto-
nin have been investigated actively using cells that were over-
expressing the relevant transporters [10–13].
The aim of this work is to investigate the absorption mecha-
nism of MDMA and its related compounds, and to determine
whether such components in tablets interact with each other in
intestinal absorption; it is in the intestines where the first steps
of pharmacokinetics occur after oral intake. In the present study,
the characteristics of MDMA uptake and interference by related
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Caco-2 cells spontaneously differentiate in culture into pola-
rized cell monolayers with microvilli, which mimic the proper-
ties of small intestinal epithelial cells [14,15]. The Caco-2 cell
line is a useful model for studying absorption in the small
intestine, since these cells retain a number of solute transport
systems including those for amino acids [16], sugars [17],
phosphates [18], bile acids [19] and dipeptides [20].
We find that the uptake rate of MDMA by Caco-2 cells is
electroneutral and is regulated by both intracellular and extra-
cellular pH. An increase in the uptake rate is observed due to
intracellular acidification or extracellular alkalinization. There-
fore, it seems that the uptake is mediated by an electroneutral
‘antiporter’ of protons. Under physiological conditions (due to
microclimate pH, pH=6 [21]), however, this antiporter seems
not to be able to concentrate the substrate because the proton
concentration is directed from outside to inside. Nevertheless,
we observe the uptake. Thus, we may infer that the substrate
(MDMA) enters into cells via this transporter due to its large
concentration difference, which induces the uphill proton trans-
port from the inside to the outside of cells. This transport system
also recognizes other compounds having amine moiety, such as
MDA, MDEA, MA and diphenhydramine.
2. Materials and methods
2.1. Materials
MA and ephedrine (EP) hydrochloride were purchased from Dainippon
Pharmaceutical (Osaka, Japan). MDMA, MDA, MDEA and dimethylamphe-
tamine (DMA) were synthesized as reported previously [22–24]. Dulbecco's
modified Eagle's medium (DMEM), non-essential amino acids (NEAA), fetal
bovine serum (FBS) and trypsin were purchased from Invitrogen Corporation
(Carlsbad, CA, USA).
2′,7′-bis(Carboxyethyl)-4(5)-carboxyfluorescein-diacetoxymethyl ester
(BCECF-AM) was purchased from Dojindo Chemical Co. (Kumamoto, Japan).
All other reagents and solvents were purchased from Wako Pure Chemical
Industries, Ltd. (Osaka, Japan). Acetonitrile was of high-performance liquid
chromatography (HPLC) grade.
2.2. Cell culture
Caco-2 cells at the 13th passage were purchased from the American Type
Culture Collection (Manassas, VA). The cells were maintained in DMEM
containing 10% FBS and 1% NEAA in an atmosphere of 5% CO2. They were
passaged in 75-cm2 culture flasks and were fed a freshmedium every 3 days [25].
At approximately 80% confluence, the cells were seeded using 0.02% ethyl-
enediaminetetraacetic acid (EDTA) and 0.05% trypsin at a density of 5.3×104
cells/cm2 on a 60-mm plastic culture dish for the uptake experiment or a 12-mm
polyester membrane insert in a 12-well plate (Transwell® insert, membrane pore
size; 0.4μm;Corning, Acton,MA) for the permeation experiment. The cells were
cultivated for 7–8 and 20–22 days before they were used for uptake and
permeation experiments, respectively. Cells between the 20th and 40th passage
were used in the present study.
2.3. Uptake experiments on Caco-2 cell monolayers
The present uptake experiments were performed in a medium consisting of
140 mM NaCl, 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2 and 5 mM D-glucose
containing 5 mM 2-(N-morpholino)ethanesulfonic acid (MES) (pH 6.0) to
imitate the acidic microclimate existing in vivo on the small intestine surface
[21]. This medium will be referred to as the incubation medium hereafter. Afterthe culture medium was removed and the cell surface was washed with 1.5 ml of
the prewarmed incubation medium (37 °C), the cells were preincubated in the
medium for 10 min at 37 °C. The medium was then removed, and the cells were
incubated with 1.5 ml of the incubation medium containing MDMA in the
presence or absence of various compounds for a designated period (0–3 min) at
37 °C. Next, the medium was removed and the cell surface was washed twice
with an ice-cold incubation medium (pH 7.4) containing 5 mM 2-[4-(2-hydro-
xyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES) instead of 5 mM MES. To
measure the uptake at time zero, the incubation medium was removed imme-
diately after its addition and the cell surface was washed twice with the ice-cold
incubation medium (pH 7.4) described above. The cells used for the uptake
experiments were stored at −30 °C until the following procedures were carried
out.
To measure MDMA uptake in the presence of 10 μM oligomycin plus
50 mM 2-deoxyglucose, the cells were preincubated with 1.5 ml of the incu-
bation medium (pH 6.0) containing these additives for 10 min at 37 °C. To
examine the influence of ion species in the medium, ion species in the incubation
medium (pH 6.0) were replaced and the cells were preincubated with 1.5 ml of
the incubation medium (pH 6.0) for 10 min at 37 °C. To examine the influence of
the membrane potential, the cells were preincubated with 1.5 ml of the incu-
bation medium (pH 6.0) containing 50 μM valinomycin for 10 min at 37 °C.
Diethylpyrocarbonate (DEPC), a specific modifier of histidine residues, was
used to examine the contributions of carrier proteins to MDMA uptake. The cells
were preincubated in the incubation medium (pH 6.0) containing 2 mM DEPC
for 10 min at 37 °C. After removing the medium, the cells were incubated for
3 min at 37 °C with 1.5 ml of the incubation medium (pH 6.0) containing
100 μM MDMA.
To examine the influence of the extracellular pH, the cells were preincubated
in the incubation medium (pH 7.4) for 10 min at 37 °C. After removing the
medium, the cells were incubated for 3 min at 37 °C with 1.5 ml of the incubation
medium (pH 7.4) containing 100 μM MDMA. Carbonyl cyanide m-chloro-
phenylhydrazone (CCCP), a protonophore, and butyrate, a weak acid, were used
to examine the influences of the proton electrochemical potential and the intra-
cellular pH. After the cells were preincubated in the incubation medium (pH 6.0)
for 10 min at 37 °C,MDMA uptake was measured in the incubation medium (pH
6.0) containing 100 μM MDMAwith 50 μM CCCP or 30 mM butyrate (short
incubation). OrMDMAuptake was measured in the incubationmedium (pH 6.0)
containing 100 μM MDMA without CCCP or butyrate after the cells were
preincubated with 1.5 ml of the incubation medium (pH 6.0) containing 50 μM
CCCP or 30 mM butyrate for 30 min (long incubation) at 37 °C.
In order to examine the effect of intracellular pH on MDMA uptake, intra-
cellular pHwasmanipulated by treating the cells with NH4Cl or butyric acid. The
treatment with NH4Cl was carried out by preincubating the cells for 10 min at
37 °C with the incubation medium (pH 7.4) in the absence (referred to as Acute
NH4Cl) or presence (Pre NH4Cl) of 30 mMNH4Cl. After removing the medium,
the cells were incubated for 3 min at 37 °C with 1.5 ml of the incubation medium
(pH 7.4) containing 100 μM MDMA in the absence (Pre NH4Cl) or presence
(Acute NH4Cl) of 30 mM NH4Cl. Another method of changing the intracellular
pH was the addition of 30 mM butyric acid. Intracellular pH was estimated by a
fluorescent pH probe (BCECF), which is described below.
2.4. Trans-stimulation experiment using diphenhydramine as a substrate
For the present trans-stimulation experiment, diphenhydramine was pre-
loaded into cells by exposing them to the incubationmedium (pH 6.0) containing
2 mMdiphenhydramine for 10 min at 37 °C. The mediumwas removed, the cells
were washed with 1.5 ml of incubation medium (pH 6.0), and the assay of the
MDMA uptake was then measured for 1 min at 37 °C in 1.5 ml of incubation
medium containing 100 μM MDMA.
2.5. Measurement of the MDMA efflux from preloaded cells
To evaluate the efflux rate of MDMA, the cells were preloaded with incu-
bation medium (pH 7.4) containing 100 μMMDMA for 10 min at 37 °C. After
removing the medium, the cells were washed with 1.5 ml of the incubation
medium (pH 7.4), and then the assay of the MDMA remaining inside the cells
was immediately initiated and continued for the designated time at 37 °C in
1.5 ml of the incubation medium (pH 6.0 or 7.4).
Fig. 1. Time course of the uptake of MDMA by Caco-2 cells. The uptake of
100 μM MDMA was measured at 37 °C in an incubation medium (pH 6.0)
whose composition is described in the text. The inset enlarges the initial uptake,
which is linear with time. Each point is the mean±S.E.M. of three experiments.
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equilibrium distribution
The cells were first preloaded with incubation medium (pH 7.4) containing
100 μMMDMA for 15 min at 37 °C, and after equilibrium, 0.1 M NaOH (20 μl)
was added into the incubation medium, bringing the pH value of the incubation
medium to approximately 8.0. The cells were incubated for the designated time
at 37 °C in the incubation medium to observe the further uptake of MDMA.
2.7. Permeation experiments by Caco-2 cell monolayers
The permeation experiment was performed in the incubation medium (pH
6.0 or 7.4) as the uptake experiment. After the culture medium was removed
from both sides of cells and the cell surface was washed with 0.5 ml (apical side)
and 1.0 ml (basolateral side) of the incubation medium prewarmed at 37 °C, the
cells were preincubated in the same medium for 10 min at 37 °C. After the
medium was removed, the apical and basolateral sides were incubated in the
incubation medium with or without 50 μM MDMA for 90 min at 37 °C. Fifty
microliters of the medium was taken from the apical or basolateral side at each
designated time point (15, 30, 60, 90 min).
2.8. Measurement of MDMA taken up and permeated by Caco-2 cells
After the uptake experiments, the cells were frozen and thawed twice, and
lysed cells were suspended in 400 μl of an extracting solution consisting of
25 mM ammonium acetate (pH 4.0) and acetonitrile in a volume ratio of 3:7 and
100 μM isoproterenol as an internal standard. After vigorous stirring, the ex-
tracting solution was transferred to a 1.5-ml microtube and shaken vigorously for
5 min, followed by centrifugation at 15,000×g for 5 min.
The supernatant was transferred to an autosampler vial for HPLC analysis.
Twenty-five microliters of the supernatant was injected into an LC column
equipped with a diode array detector (LC-10AD with SPD-M10A; Shimadzu,
Kyoto, Japan). Chromatographic separation was achieved using a polymer-
coated strong-cation exchange column (CAPCELL PAKSCXUG80, 250mM×
1.5 mM i.d.; Shiseido, Tokyo, Japan) at 40 °C. The mobile phase was 25 mM
ammonium acetate (pH 4.0) and acetonitrile (3:7 in volume). The flow rate was
maintained at 0.3 ml/min, and the monitoring wavelengths were 235 and 280 nm
for MDMA and isoproterenol, respectively.
After the permeation experiments, the permeate obtained was diluted with
200 μl of a solution consisting of 25 mM ammonium acetate (pH 4.0) and
acetonitrile in a volume ratio of 3:7 and 100 μM isoproterenol as an internal
standard. The samples were analyzed as described above.
For all uptake measurements, values were corrected based on the protein
contents. After the supernatant in the tube was removed, the precipitate was
solubilized in 1 ml of 1 M NaOH to measure the protein contents. The protein
contents of the cell monolayers were measured with a Bio-Rad protein assay kit
(Bio-RadLaboratories, Philadelphia, PA) using bovine serumalbumin as a standard.
2.9. Kinetic analysis of MDMA uptake
The initial uptake rates of MDMA were estimated using linear regression
analysis of the linear portion of the curve of uptake versus time. The data were
fitted to a Michaelis–Menten type equation by an iterative nonlinear least-square
method:
V ¼ Vmax½S=ðKm þ ½SÞ þ Kd½S ð1Þ
where V represents the initial uptake rate of substrate; Vmax, the maximum uptake
velocity; [S], the initial concentration of substrate; Km, the Michaelis–Menten
constant; and Kd, the coefficient of the passive diffusion. The initial uptake rates
of MDMA were measured under various conditions, and the values were
presented as the ratio of the MDMA uptake rate to the uptake rate of 100 μM
MDMA in incubation medium (pH 6.0) without an inhibitor.
2.10. Measurement of intracellular pH
The intracellular pH of Caco-2 cells was measured using the fluorescent
probe BCECF. Cells grown in 75-cm2 culture flasks were trypsinized andsuspended in the incubation medium (pH 7.4) at 1×107 cells/ml. Membrane-
permeable BCECF-AM of 3 μM was added to the cell suspension, which was
then incubated at 37 °C for 30 min. After the cells were washed twice with the
incubation medium, the cells loaded with membrane-impermeable BCECF were
suspended at 1×106 cells/ml in the incubation medium with various compounds
for 10 min at 37 °C. The fluorescence intensity of BCECF was monitored using
a spectrofluorophotometer (Shimadzu RF-5000) with excitation at 500±5 nm
and emission at 530±5 nm. Intracellular pH was calibrated at different pH
values between 6.2 and 8.2 using a calibration medium containing 130 mMKCl,
10 mM NaCl, 1 mM MgSO4 and 10 mM MES, and containing 10 μg/ml
nigericin.3. Results
3.1. Carrier-mediated MDMA uptake by Caco-2 cells
The uptake of MDMA by Caco-2 cells was measured in the
range of 0–30 min. Fig. 1 shows the time course for the uptake
of 100 μM MDMA in the incubation medium (pH 6.0). Line-
arity is observed up to 3 min and the uptake reaches a plateau
after 5 min. Because the uptake at time zero was the same as that
at 4 °C, the uptake at time zero can be attributed to rapid
adsorption to the cellular surface. Therefore, the initial uptake
rate was calculated from the slope of the linear portion (0–
3 min; see inset of Fig. 1).
Fig. 2 shows the relationship between the initial uptake rate
and MDMA concentrations in the incubation medium (pH
6.0). The uptake was saturated at a high MDMA concentra-
tion. The inset in Fig. 2 shows an Eadie–Hofstee plot in
which the line leans toward the lower right. The kinetic
parameters were calculated by fitting the data to Eq. (1), and
Km andVmaxwere 1.11±0.12mM (±S.D.) and 13.79±0.76 nmol/
min/mg protein, respectively. It is noted that Kd was nearly
zero, implying that the passive diffusion hardly contributed to
the kinetics. The uptake rate of 100 μM MDMA at 4 °C
(0.157±0.037 nmol/min/mg protein) was much lower than that
at 37 °C. As will be described later, compounds having an
amine moiety similar to that of MDMA inhibited the uptake of
Fig. 2. Concentration dependence of the MDMA uptake rate by Caco-2 cells.
The initial uptake rate was determined by linear regression analysis of the linear
portion of the MDMA uptake versus time plot. The inset is an Eadie–Hofstee
plot of the MDMA uptake. The experimental conditions were the same as those
of Fig. 1. A fitting curve was drawn using the iterative nonlinear least-squares
method. Each point is the mean±S.E.M. of three experiments.
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cells preloaded with the substrate diphenhydramine (see
below). These findings reveal that MDMA uptake is mediated
by a carrier protein.Fig. 3. Effects of various experimental conditions on MDMA uptake by Caco-2 cells.
6.0 except for “pH 6.0→7.4”) for 3 min at 37 °C under various conditions as describe
were replaced. “Short incubation” indicates that MDMA uptake was measured in the
30 mM butyrate after the cells were preincubated in the incubation medium (pH 6
measured in the incubation medium (pH 6.0) containing 100 μM MDMAwithout C
medium (pH 6.0) containing 50 μMCCCP or 30 mM butyrate for 30 min at 37 °C. St
value is the mean±S.E.M. of three experiments.3.2. MDMA uptake under various conditions
Uptake rates were measured under various conditions (see
Fig. 3). First, we checked the dependency of the intracellular
adenosine triphosphate (ATP) concentration. When the intra-
cellular ATP level was reduced to approximately 20% of the
control by the addition of 10 μM oligomycin together with
50 mM 2-deoxyglucose [25], the uptake rate showed almost no
change. Various Na+-dependent carriers, such as transporters of
amino acids [16], sugars [17] and phosphates [18], have been
reported. In the present study, we replaced Na+ with Li+ in the
incubation medium, finding no change in MDMA uptake. Be-
cause the solubility of I− in the lipid phase is approximately 20
times higher than that of Cl−, the replacement of Cl− with I− in
an extracellular medium creates a more negative membrane
potential in an intracellular compartment [26]. However, this
substitution had no observable effect, as shown in Fig. 3. The
membrane potential-independent uptake was also confirmed by
the observation that the addition of valinomycin (50 μM) to the
medium had no effect on MDMA uptake (Fig. 3). MDMA
uptake was partially inhibited by DEPC, which modified the
histidine residues on the cells [27,28]. The results support the
notion that MDMA transport is carrier-mediated. Based on
these observations, we infer that this carrier-mediated MDMAThe uptake rate of 100 μMMDMAwas measured in the incubation medium (pH
d in the text. Arrows indicate that ion species in the incubation medium (pH 6.0)
incubation medium (pH 6.0) containing 100 μMMDMAwith 50 μM CCCP or
.0) for 10 min at 37 °C. “Long incubation” indicates that MDMA uptake was
CCP or butyrate after the cells were preincubated with 1.5 ml of the incubation
atistical analysis was done by Student's t-test. ⁎Pb0.05 versus the control. Each
Fig. 5. MDMA efflux from preloaded Caco-2 cells. The cells were preloaded
with incubation medium (pH 7.4) containing 100 μM MDMA for 10 min at
37 °C. After the medium was removed, the cells were washed with 2 ml of the
incubation medium (pH 7.4) at 37 °C, and then immediately treated for the
designated time (0.5, 1 or 5 min) at 37 °C with 1.5 ml of the incubation medium
(pH 6.0 or 7.4). The amounts of MDMA remaining in the cells were measured.
Statistical analysis was carried out using the Student's t-test. ⁎Pb0.05 versus
the control (pH 6.0). Each value is the mean±S.E.M. of three experiments.
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dependent, but rather is an electroneutral process.
In contrast, we observed significant pH dependence, as
shown in Fig. 3. When the pH of the incubation medium was
increased from 6.0 to 7.4, MDMA uptake increased signifi-
cantly. To examine the coupling of the proton electrochemical
potential, the protonophore, CCCP, was added to the incubation
medium (pH 6.0) containing MDMA. However, we observed
no effect (Fig. 3), indicating that this transport is not driven by
the difference in the proton electrochemical difference, that is,
the proton motive force. The uptake of MDMA was enhanced
only when CCCP was preincubated for a long time (30 min).
Therefore, we must distinguish between two CCCP treatments
based on whether they involve a ‘short’ or ‘long’ incubation.
Short incubation of CCCP did not affect the uptake rate.
3.3. Effects of intra- and extracellular pH on uptake and efflux
of MDMA
Having observed the effect of extracellular pH on uptake
(Fig. 3), we next examined the effect of intracellular pH. We
used treatment with NH4Cl to change the intracellular pH
levels. Exposure of the cells to NH4Cl (acute NH4Cl) has been
found to cause a rapid increase in pH [29]. As shown in Fig. 4,
this treatment (causing intracellular alkalinization) decreases the
uptake rate, while the pre-NH4Cl treatment (causing intracel-
lular acidification) increases uptake. Details of both treatments
are given above in the Materials and methods section.
Another method of changing intracellular pH is to use a weak
acid, butyrate (30 mM); a neutral form of butyrate may enter the
intracellular space, where the acid may dissociate and thus
decrease pH. However, when 30 mM of butyrate was added in
the present experiments, only a slight inhibition was observed
on the uptake rate (see short incubation of butyrate in Fig. 3).Fig. 4. Effect of NH4Cl treatment on MDMA uptake by Caco-2 cells. The cells
were preincubated for 10 min at 37 °C with the incubation medium (pH 7.4) in
the absence (control, acute NH4Cl) or presence (pre-NH4Cl) of 30 mM NH4Cl.
After removing the medium, the cells were incubated for 3 min at 37 °C with
1.5 ml of incubation medium (pH 7.4) containing 100 μM MDMA in the
absence (control, pre-NH4Cl) or presence (acute NH4Cl) of 30 mM NH4Cl. The
uptake of MDMAwas measured in each incubation medium. See the text for a
discussion of the intracellular pH changes brought about by this treatment.
Statistical analysis was performed using the Student's t-test. ⁎Pb0.05 versus the
control. Each value is the mean±S.E.M. of three experiments.However, when the cells were incubated in the presence of
30 mM butyrate for 30 min, an increase in the uptake rate was
observed (see long incubation of butyrate in Fig. 3), and
intracellular pH decreased from 6.94±0.03 to 6.55±0.03, as
estimated by BCECF. The reason that such a long incubation is
required in order for an effect to be discernible may be that
butyric acid is transported very slowly. Another possibility is
that butyrate may be metabolized to other acidic substances.
We observed a similar effect on CCCP. As described
above, a short incubation period of CCCP did not produce
any effect (see short incubation of CCCP in Fig. 3). However,
long incubation (for approximately 30 min) resulted in an
appreciable increase in the uptake rate (see long incubation of
CCCP in Fig. 3). We considered it very strange that the
presence of CCCP, which is an uncoupler, enhances the
uptake rate. Therefore, we measured intracellular pH with
BCECF [30], which decreased as expected to 6.64±0.02. The
addition of CCCP for 30 min would modulate the proton-
coupled transporters of the cell membrane to change the
intracellular pH, while a shorter application of CCCP would
not be expected to bring about any significant change in pH.
MDMA efflux was measured from preloaded cells, and the
results are shown in Fig. 5. Efflux rates were found to increase
as extracellular pH decreased. Thus, the outwardly directed
proton concentration gradient accelerates the uptake of MDMA
while a proton gradient in the reverse direction accelerates the
efflux, indicating an antiport system in which both protons and
MDMA participate. In addition, the effects of extracellular pH
on the equilibrium of MDMA distribution by Caco-2 cells were
examined (Fig. 6). After MDMA in Caco-2 cells reached equi-
librium by incubating the cells in MDMA-containing medium
(pH 7.4) at 37 °C for 15 min, NaOHwas added to the incubation
medium. The increase of the extracellular pH led to the uptake
of MDMA. This observation also implies that this antiporter can
concentrate MDMA by an outwardly directed proton gradient.
Fig. 6. Effects of extracellular pH on the equilibrium of MDMA distribution by
Caco-2 cells. The uptake of 100 μM MDMA was measured in the incubation
medium (pH 7.4) at 37 °C for 15 min, allowing the MDMA distribution to attain
equilibrium, and the extracellular pH level was then changed to approximately
8.0 by the addition of 0.1 M NaOH (20 μl) to the incubation medium. The arrow
represents the addition of aqueous NaOH. Each point is the mean±S.E.M. of
three experiments.
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The permeations of MDMA from the apical to the basolateral
side (from A to B) or from the basolateral to the apical side
(from B to A) through Caco-2 cells were measured in the range
of 15–90 min (Fig. 7). The linearity of permeation in both
directions was observed up to 90 min. The permeation rate was
determined by linear regression analysis of the permeation plot
from 15 to 90 min. When an H+ concentration gradient from A
(pH 6.0) to B (pH 7.4) was created, the rate of permeation from
B to A was approximately 10 times higher than that of per-Fig. 7. Time courses of the permeations of MDMA from the apical to the
basolateral side and from the basolateral to the apical side through Caco-2 cells.
After the incubation medium (pH 6.0 or 7.4) containing 50 μM MDMA was
added to the apical or basolateral side, the permeation was measured for 90 min.
“A (pH 6.0) to B” indicates that the incubation medium (pH 6.0) containing
MDMAwas added to the apical side, and then the permeation of MDMA to the
basolateral side (pH 7.4) was measured. The permeation rate was determined by
linear regression analysis of the permeation plot from 15 to 90 min. Each point is
the mean±S.E.M. of three experiments.meation from A to B, and even without an H+ concentration
gradient (pH 7.4 on both sides), the rate of permeation from B to
A was approximately 1.4 times higher than that of permeation
from A to B. These facts imply that the efflux of MDMA is
superior to the uptake under physiological conditions (see later
discussion and Fig. 10). Nevertheless, we observed a transport
from the apical to the basolateral side.
3.5. Specificity of MDMA uptake
We examined the effects of various compounds (1 mM) on
100 μM of MDMA uptake (Table 1). When ATSs such as
MDA and MDEA, whose chemical structures are similar to that
of MDMA, were added to the incubation medium containing
MDMA, uptake was inhibited, and MDEA greatly inhibited
MDMA uptake in comparison with the other compounds. Vari-
ous cationic drugs and compounds in ATS tablets were also
examined. Diphenhydramine was found to strongly inhibit
MDMA uptake in all tested compounds other than ATSs, while
caffeine, which is frequently included in ATS tablets, did not
change the MDMA uptake.
To evaluate the inhibition of MDMA uptake by diphenhy-
dramine, a Dixon plot was generated (Fig. 8). The inhibition of
MDMA uptake by diphenhydramine was competitive, and Ki,
which was estimated using the intersection of the lines obtained
from two concentrations of MDMA, was found to be approxi-
mately 2 mM, a value which was similar to the Km value of
MDMA uptake. Moreover, a trans-stimulation experiment was
performed using cells preloaded with diphenhydramine in order
to determine whether MDMA is taken up though the transporter.
The uptake of MDMA at 1 min was significantly enhanced
(136.7±9.0% (n=3)) compared to the control by preloading withTable 1
Inhibitory effects of various compounds on MDMA uptake
Compounds Uptake (percent of control)
MDA 59.4±16.5⁎
MDEA 39.6±2.1⁎
MA 73.7±9.0 ⁎
EP 87.3±2.1⁎
DMA 59.0±2.7 ⁎
Ketamine 79.0±10.1⁎
Diphenhydramine 65.1±0.4 ⁎
Clonidine 76.4±6.0 ⁎
Caffeine 98.8±2.2
TEA 100.4±7.7
MPP+ 90.0±7.7
Guanidine 93.5±3.1
Verapamil 91.7±6.4
β-Phenetylamine 59.8±2.7 ⁎
4-Phenyl-1-butanamine 32.1±4.4 ⁎
Tyramine 75.3±7.3 ⁎
Phenylalanine 103.8±11.4
Tyrosine 104.0±9.2
The uptake rates of 100 μM MDMAwere measured in the absence or presence
of various compounds (1 mM). Experimental conditions were as described in the
text. Statistical analysis was done by Student's t-test.
⁎ Pb0.05 vs. the control (pH 6.0). Each value is the mean±S.E.M. of three
experiments.
Fig. 9. The chemical structures of MDMA and its related compounds tested in
the present study.
Fig. 8. Concentration-dependent inhibition of MDMA uptake by diphenhydra-
mine. The uptake rates of MDMA at two concentrations (0.1 and 0.5 mM) were
measured in the incubation medium (pH 6.0) at 37 °C in the absence or presence
of diphenhydramine (1 or 5 mM). A Dixon plot of MDMA uptake against
diphenhydramine concentrations was generated. The lines at each concentration
of MDMA were drawn by linear regression analysis. Each point is the mean±
S.E.M. of three experiments.
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diphenhydramine are transported by a common carrier.
Mizuuchi et al. demonstrated that diphenhydramine is
transported by the pH-dependent tertiary amine transport system
in Caco-2 cells [29] and in rabbit intestinal brush border mem-
brane vesicles [31]. The transport system is able to recognize
N-dimethyl or N-diethyl moieties in the structures. MDMA is,
however, a secondary amine that possesses an N-methyl
moiety in its structure.
Organic cation transporters (OCT) 1, 2 and 3 mediate the faci-
litated transport of a variety of structurally diverse organic cations
and are broadly expressed in the liver, kidney and intestine [32].
Tetraethylammonium (TEA) and 1-methyl-4-phenylpyridinium
(MPP+) [33], typical substrates of OCTs, did not inhibit MDMA
uptake in the present experiments. On the other hand, tyramine,
which is a substrate for rat OCT-1 and human OCT-3, was found
to inhibit the uptake. Although a guanidine/H+ antiporter in
intestinal brush border membrane vesicles has been reported [34],
guanidine did not inhibit MDMA uptake in the present study.
Verapamil, a P-glycoprotein substrate [35], had no effect on
MDMA uptake. In addition, because MDMA uptake is ATP-
independent, P-glycoprotein is believed to have no relation with
MDMA uptake. Recently, a proton-coupled efflux transporter
(MATE) was reported [36–38]. The substrates of MATE are dif-
ferent from those of this transport system. Although the
spectrum of substrate recognition in the present case seems to
be different from that of many transport systems reported pre-
viously [36–41], the specificity and mechanism of MDMAwere
similar to those of the clonidine uptake reported recently [42].
3.6. Relationship between structure and the recognition of the
MDMA transport system
Substrate recognition was examined using various com-
pounds having structures similar to that of MDMA. All com-pounds that inhibited MDMA uptake possessed aliphatic amino
moieties. Fig. 9 shows the structures of MDMA-related
compounds tested in the present study. Although the structures
of diphenhydramine, ketamine and clonidine differ greatly from
that of MDMA, these compounds seem to be recognized by the
MDMA transport system because of the presence of an aliphatic
amino moiety. The inhibitory effects tended to become larger in
the order of primary, secondary and tertiary amine moiety
judging from the comparison of MDAwith MDEA, and of MA
with DMA. Quaternary ammonium compounds such as TEA
and MPP+ did not, however, inhibit MDMA uptake at all.
As the carbon chain of the aliphatic amino moiety was longer,
the inhibition against MDMA uptake was greater (Table 1,
β-phenethylamine and 4-phenyl-1-butanamine). and tyrosine,
neutral aromatic amino acids, did not inhibit MDMA uptake.
EP, MA having a 2-hydroxy moiety, and tyramine, β-phenethy-
lamine having a p-hydroxyl moiety, showed a weaker inhibition
against MDMA uptake than MA and β-phenethylamine, res-
pectively. Thus, carboxyl and hydroxyl moieties were considered
to interfere with the recognition of the transport system.
4. Discussion
The present paper reveals, for the first time, that MDMA can
be transported by an electroneutral proton-coupled transport
system. Since the pKa value of MDMA is 10.1 [43], almost all
MDMA molecules are present in a positively charged form.
Because of the electroneutral transport, the transport system
should be an antiporter with H+ in the ratio of 1:1. Our present
results show that alkalinization of extracellular pH or acidi-
fication of intracellular pH increases the uptake rate, that is, an
increase in the gradient of the outward proton concentration
increases the uptake rate. This experimental finding may suggest
that MDMA uptake is mediated by an antiporter driven by the
outward movement of H+.
Fig. 10. The presumptive transport mechanism of MDMA uptake. X−, XH and
XS indicate the empty transporter, the protonated transporter and the substrate-
associated transporter, respectively. For details, see Discussion.
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experimental condition of a medium pH of 6.0, however, this
process should not occur because the proton concentration
gradient is in the reverse direction due to the acidic pH micro-
climate [40,44]. What, then, is the mechanism of MDMA up-
take? We assume the transport cycle shown in Fig. 10. In this
figure, X−, XH and XS indicate the empty transporter, the
protonated transporter and the substrate-associated transporter,
respectively. Since the transport is electroneutral, and since the
pH in both the extracellular and intracellular spaces regulates
the transport rate, we assume here that the empty transporter
bears a negatively dissociated amino acid residue denoted by
X−, with which H+ or S+ binds. Note that the pKa value of
MDMA is 10.1, and that MDMA is then protonated and posi-
tively charged as denoted by S+. As the intracellular pH
decreases, the X− ↔ XH reaction at the intracellular membrane
surface shifts to a decrease in X−, giving rise to an acceleration
of the release of S+. A similar but reverse pH dependence occurs
on the extracellular side.
Furthermore, we assume that this transport system is revers-
ible (Fig. 5), meaning that the transport cycle shown in Fig. 10
can rotate either clockwise or counter-clockwise depending on
the magnitude of the proton gradient and the substrate concen-
tration gradient. If {[H+]out− [H+]in}≫{[S+]out− [S+]in}, this
transport system functions as a proton-coupled efflux pump
(antiporter with proton; clockwise rotation in Fig. 10). Note that
under the usual physiological conditions, the relation [H+]outN
[H+]in usually holds. Nevertheless, if the relation {[S
+]out−
[S+]in}≫{[H+]out− [H+]in} holds, the uptake of substrate S+
that follows its concentration gradient may occur due to the
reverse rotation of the transport cycle of the antiporter, i.e., by a
counter-clockwise rotation of the transport cycle shown in
Fig. 10. Such a bidirectional transport has been demonstrated in
other transporters [45–47]. This condition holds at present,
because {[H+]out− [H+]in} is approximately on the order of μM
while {[S+]out− [S+]in} is 0.1 to 2 mM. When we confine
ourselves to the movement of the substrate, it may be said that
the uptake of substrate is mediated by a ‘facilitated transporter’.
If the transport system shown in Fig. 10 is indeed present it
may be possible to allow the transport system to function as an
antiporter with H+, as discussed above. This was done in the
present study and the results are shown in Fig. 6. First, MDMA
was loaded into cells under the condition of an equivalent pH
inside and outside cells. After the MDMA distribution reached
equilibrium, the extracellular pH was increased to create a
proton gradient from the inside to the outside of the cells. As
shown in Fig. 10, this pH change induces the further uptake of
MDMA, which is consistent with the scheme shown in the
figure. After 25 min, the intracellular MDMA decreased, pos-
sibly due to the efflux of MDMA in accordance with its concen-
tration difference. This suggests the reversibility of the transport
system.
As mentioned above, the clockwise rotation of the transport
cycle indicates a proton-coupled efflux pump, which is more
likely under the physiological conditions than the ‘facilitated
transporter’. The results in Fig. 7 support the notion that this
transport system functions as a proton-coupled efflux pump.Moreover, Fig. 7 implies that the pH changes of the acidic
microclimate on the apical membrane affect the transport sys-
tem. We must take this transport system into consideration when
we examine the bioavailability of drugs having an amine moi-
ety, because this transport system might serve as a proton-
coupled efflux transport system under certain conditions, and
function as a proton-moving facilitated transporter under other
conditions. In addition, based on the observed substrates, the
present transport system might be a novel one. Here, we did not
pay attention to lysosomal trapping of alkaline compounds
because we focused on the initial uptake over the short term.
This accumulation, however, should be considered when the
distribution of MDMA is investigated. In addition, further in-
vestigation will be needed into such issues as molecular cloning
and biochemical characterization.
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